You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › March › 06
FDA
4 months ago
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
FDA reversals leave investors worrying about the fates of other experimental drugs ⊖
Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S. Food and Drug Administration.
page 1 of 1